Discover the full record of transactions filed by VAGELOS P ROY, Director. Director active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 10 disclosures have been logged. Total volume traded: €9m. The latest transaction was filed on 30 March 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Roy P. Vageos is a Board Member of REGENERON PHARMACEUTICALS, INC. He contributes to the governance of the company, bringing his experience in the pharmaceutical sector to guide strategic decisions.